Diabetech - Diabetes Tech, Research, News
Diabetech covers diabetes technology, news, research, and management tips through interviews with industry leaders and those using and building the tech. Topics include insulin pumps, continuous glucose monitors (CGMs), clinical trials, treatment advancements, and on-location reporting from top diabetes conferences.
Episodes
Trio & The Future of Open Source AID
Trio version 1.0 is here! This is the largest system update to date for the open-source automated insulin delivery (AID) system. The latest release adds new pump and CGM integrations, a redesigned app, customizable alerts, glucose forecasts, and new features like Quick Picks. This episode explores how Trio’s open-source approach differs from commercial AID systems and how users can customize the s
Why Your Pump & CGM Stop Talking Underwater
Your pump and CGM lose connection in the pool, and it comes down to centimeters. I sat down with Dr. Michael Hughes, an endocrinologist at Emory University, to break down his research on swimming with automated insulin delivery (AID). His team found the connection held at 100% at 10 cm, dropped to about half at 13 cm, and hit 0% by 17 cm, so where you place your pod and CGM matters a lot for swimm
How to Master Your AID System - ODT
Are you getting the most out of your automated insulin delivery system, or are you still managing it like a traditional insulin pump? Gary Scheiner, CDCES, and I break down 10 ways to optimize your AID system, from fine-tuning pump settings and knowing when to bolus to treating lows and timing insulin more effectively. We also cover how to trust the algorithm, use advanced pump features for exerci
Libre Duo - The First Dual Glucose-Ketone Sensor
Abbott's VP of Technical Operations and Senior Medical Director break down the new Libre Duo sensor, the first continuous glucose ketone monitor. We discuss the growing need for more ketone data, how ketone alerts will appear in the existing Libre app, and why the company designed the experience to minimize alert and information fatigue. The conversation also covers Libre Duo’s compatibility with
The Cure for T1D - Inside the Eledon Trial
Eledon's CEO, Dr. David-Alexandre Gros, breaks down Tegoprubart, the company’s targeted immunosuppressant being studied alongside islet cell transplants for type 1 diabetes. The conversation covers the promising results seen so far, including insulin independence and improved A1C levels among trial participants, and why Tego could offer a different approach to protecting transplanted cells. The ep
Inside Europe’s Insulin Pump Market
Ever wonder what insulin pump options exist outside the U.S.? Dr. Inge Van Boxelaer, a Belgian endocrinologist and founder of Diabetotech, joins us on the podcast and breaks down the European AID system landscape. We cover how MiniMed, Tandem, and Omnipod are performing across European markets, plus a deep dive into European systems like the Kaleido, mylife YpsoPump (with CamAPS FX and the upcomin
What Will a Type 1 Diabetes Cure Actually Look Like?
Part two of this series continues the conversation about what a cure for type 1 diabetes could actually look like, from cell replacement and immune therapies to insulin innovation and advanced diabetes technology. The discussion explores islet cell transplants, stem cell-derived beta cells, immune suppression, gene-edited cells, and the challenges of making these approaches safer and more widely a
Could Prevention be the Cure for Type 1 Diabetes?
In this episode, I sit down with leading type 1 diabetes researchers and clinicians to break down the science behind prevention, delaying disease progression, and replacing insulin-producing beta cells. We explore promising therapies like teplizumab, ATG, and verapamil, along with the challenges of immunotherapy, beta cell replacement, and making these treatments accessible to more people. This co
Diabetes Survival Skills - How to Prepare for Emergencies
When your CGM fails, your pump dies, or you're caught in a situation without access to your tech, do you know what to do? Gary Scheiner and I break down the "back to basics" skills every T1D needs to know from manual carb counting to calculating correction doses without a pump, to safely transitioning from a pump to MDI (and back again). We also cover what belongs in your diabetes emergency go-bag
A Vertex Participant Cured of Type 1 Diabetes Shares Her Story
A cure for type 1 diabetes has always felt like a distant idea, but for Patti Columbe, it's now her reality. After living with type 1 for 40 years, Patti shares her journey as a participant of the Vertex VX-880 clinical trial, where a lab-grown islet cell transplant has left her insulin-free and functionally cured. She opens up about the emotional challenges of adapting to life without diabetes an
MiniMed Flex So Far - Speaking with Users
MiniMed’s new tubed insulin pump is finally here, and early users are beginning to share what life with the new insulin pump is really like. Our guests discuss using the system, the transition from previous pumps, what surprised them most, and how the smaller, app-controlled pump has impacted their day-to-day. The conversation also explores MiniMed's Meal Detection technology, how the algorithm ha
The Implantable Insulin Pump & Why Patients Fought to Keep it
Greg Peterson has lived with type 1 diabetes for nearly 70 years and used an implantable insulin pump for more than two decades, even traveling from the U.S. to France to maintain it after the technology was discontinued. He shares how the implantable pump worked, how it dramatically improved his quality of life, and the profound impact it had on managing highs and lows as well as his relationship
All the U.S. Pumps Compared - Which is Right for You?
I sat down with diabetes technology expert, and pharmacist, Diana Isaacs to compare every AID pump currently available in the Unites States. We dive into how each system works, who it's best suited for, and the features that truly set them apart; from Omnipod 5's tubeless form factor and Sequel's twiist DIY roots to Tandem's Control-IQ+ algorithm, the screenless MiniMed Flex, and the ease of Beta
How to Eat with Diabetes: Top Carb Counting Tips
Gary Scheiner, CDCES, and I break down why carb counting is one of the trickiest parts of managing type 1 diabetes, and why getting it "close enough" is often more realistic than getting it perfect. We dive into how fat, protein, fiber, and alcohol each affect blood sugar differently, plus why insulin timing matters just as much as the dose. Gary shares practical estimation strategies like the han
ADA 2026 Diabetes Tech News Roundup
ADA 2026 Scientific Sessions brought a wave of exciting diabetes technology announcements, and Endo Dr. David Ahn and I dig into all of it in a live recording of the podcast! From a hands-on look at the new MiniMed Flex to updates from Tandem, Omnipod, twiist, and the open-source community, our discussion explores how these innovations could shape the future of diabetes care. We also dive into Abb
How T1D Pilots Fought For The Right To Fly
Commercial airline pilot John Roth shares how his diagnosis grounded him in 2015 and forced him to step away from the cockpit. Through years of advocacy, legal challenges, and advances in diabetes technology, John helped pave the way for pilots with type 1 diabetes to regain their right to fly. The conversation explores the emotional toll of losing a passion, the role CGMs played in changing FAA p
Inside MiniMed Flex & First Look at its Tubeless Pump!
I sat down with MiniMed's CTO to explore the new app-controlled pump, the MiniMed Flex and walk through its redesigned app ecosystem. We also discussed the next-generation Vivera algorithm, designed to reduce or potentially eliminate the need for meal boluses while improving time in range for users. And in a surprise reveal, MiniMed gave us an early look at the upcoming tubeless patch pump called
She's "Cured" from Type 1 Diabetes
Katie Beth Hand, patient 9 in the Eledon trial, received an islet cell transplant in January 2026. She is now living a "functionally cured" life, but every 21 days she requires a transfusion of an immunosuppressant called Tegoprubart which stops her body from attacking the newly implanted islet cells. In this conversation, we get into how the trial works, what it feels like to stop taking insulin
Dexcom Exec Interview: G7 Fixes and the Future of G8
Dexcom has heard the community's concerns around sensor accuracy, connectivity, adhesive performance, and transparency. In this episode, I sit down with Dexcom CEO Jacob Leach and CTO Peter Simpson to discuss how the company is addressing those concerns, improving the Dexcom G7, and working to rebuild trust with users. We also get an exclusive look at the future of Dexcom, including enhanced algor
Why Schools are Failing Kids with Type 1 Diabetes
Sending a child to school with type 1 diabetes should be easier in 2026. In this episode I break down why it remains one of the most stressful parts of managing the disease. I sit down with Dr. Taylor Inman, a physician and parent of a child with type 1 diabetes, to unpack the major gaps in school-based diabetes care despite widespread use of CGMs and insulin pumps. We explore how outdated policie
How To Exercise with T1D & Stay in Range
We break down why exercise can be one of the most challenging parts of living with type 1 diabetes. We dive into how different types of workouts affect blood sugar, how to prevent highs and lows during exercise, and how to use insulin pumps, CGMs, and diabetes technology more effectively while staying active. Gary shares practical strategies for adjusting insulin, timing carbs, using exercise mode
Stash: The Diabetes App for Supply Tracking & Travel
I’m joined by Cory Zapatka, the developer of the Stash app. We dive into how the app works—from barcode scanning and inventory tracking to recall alerts, a trip planner, and an infusion site tracker—and how it can simplify the day-to-day chaos of diabetes management. Cory also shares how he built the app without a traditional coding background using AI tools, and what that says about the future of
Why Some CGMs May Be Less Safe Than You Think
Continuous glucose monitors (CGMs) play a major role in diabetes management, but not all CGM accuracy and testing standards are the same. In this episode, I sit down with John Pemberton of Glucose Never Lies to break down how CGMs are tested, and why FDA clearance and CE marking aren’t equivalent when it comes to insulin dosing safety. As diabetes technology moves toward automated insulin delivery
I Used the twiist Pump for 2 Months - Here's How it Went
I share my unfiltered review of the twiist insulin pump, diving deeper into my personal experience after two months of real-world use. I go beyond a standard review to break down how features like Apple Watch control, glycemic index-based carb logging, and retroactive carb adjustments performed in my day-to-day life. I also get the highs and lows, from strong glucose control and 87% time in range
Why You Keep Going Low (And How to Fix It) - ODT
Gary Scheiner, CDCES, and I break down why hypoglycemia (low blood sugar) is one of the most dangerous and frustrating parts of living with diabetes. We dive into how to prevent low blood sugar, reduce the frequency and severity of hypos, and avoid rebound highs using insulin pumps, CGMs, and smarter insulin timing. Gary shares practical strategies for adjusting settings, treating lows without ove
$11 Insulin for All? Inside the Nonprofit Rewriting U.S. Drug Prices
I sit down with Allan Coukell, Civica's Chief of Government Affairs & Public Policy Officer, to explore how its nonprofit insulin model and California’s CalRx partnership are bringing low-cost insulin—priced around $11 per pen and $30 per vial—to people nationwide, with or without insurance. We break down how pharmacy benefit managers, rebates, and the current drug pricing system have kept ins
How Blue Circle Health's Free Type 1 Support Works
I sat down with Dr. Monica Gomberg and Sherry Roberts from Blue Circle Health to explore how they’re redefining care for adults living with type 1 diabetes. We break down the real gaps in our healthcare system—from insurance battles and financial barriers to diabetes distress—and how this free, nationwide program helps people access endocrinology care, certified diabetes education, CGMs, and even
Inside the twiist + Eversense 365 Integration
I spoke with leaders from Senseonics and Sequel MedTech to unpack a major first in diabetes tech—the integration of the Eversense 365 implantable continuous glucose monitor with the twiist insulin pump for automated insulin delivery. We explore how this implantable CGM works, what makes it different from traditional sensors, and how the new looping system connects through dual apps to support a mo
Optimizing Mealtime Insulin for Better Post-Meal Glucose - ODT
Gary Scheiner, CDCES, and I break down how to improve mealtime insulin dosing and why boluses still matter even with automated insulin delivery systems. We talk through insulin-to-carb ratios, pre-bolus timing, extended boluses, and how different foods impact post-meal blood sugar patterns. Gary shares practical ways to read your CGM data to tell whether highs and lows are caused by timing, dosing
ATTD 2026: Biggest Diabetes Tech News Roundup
I spoke with endocrinologist and diabetes tech expert Dr. David Ahn at the ATTD conference about the biggest breakthroughs shaping the future of diabetes management, including the rapid progress toward fully closed-loop insulin delivery systems. We explored how companies like MiniMed, CamAPS, and Omnipod are advancing automation that reduces carb counting, minimizes manual bolusing, and improves t
The Road to a T1D Cure - Inside the Islet Cell Act & Eledon Trial
I spoke with journalist and cure expert Ginger Vieira to unpack major developments including stem-cell therapies, donor islet cell transplants, and the growing debate around the Islet Cell Act currently stalled in U.S. Congress. We examine why promising results from trials like Eledon's still face challenges around safety, scalability, and immunosuppression despite exciting early outcomes and brea
Detained by ICE and Denied Insulin for Days - She Shares Her Story
I sit down with Hanne Engan to discuss her experience being detained by ICE during what was supposed to be a routine U.S. green card interview. We unpack how immigration enforcement policies intersected with a life-threatening medical crisis when Hana—who has type 1 diabetes—was denied critical insulin and medical care inside an immigration detention center. Through her firsthand account, we explo
How to Optimize Your Insulin for Better Time in Range - ODT
Gary and I break down why insulin doesn’t always work the way we expect—whether it’s absorption issues, site problems, heat exposure, stress, hormones, illness, or exercise. We talk about how automated insulin delivery systems are only as good as the insulin actually getting into your body, and why fixing efficacy often matters more than changing your settings. Gary shares practical strategies for
Inside Patient #1’s Islet Transplant Without Immunosuppression
I speak with the first patient in a groundbreaking type 1 diabetes cure research trial using encapsulated neonatal pig islet cells—without immunosuppression. Six months after his transplant through the OPF-310 study led by Otsuka Pharmaceutical and University of Illinois Chicago, Michael Revland's insulin needs have been cut in half as the cells have begun maturing and producing insulin. We dive i
Inside the FDA: Clearances, Recalls & Today’s Politics
I’m joined by Naomi Schwartz, former FDA diabetes reviewer and VP of regulatory strategy at Medcrypt, who shares firsthand insight into how device classifications, De Novo pathways, and FDA warning letters work. We break down why the FDA can feel like a barrier to innovation, how DIY diabetes tech and cybersecurity risks are evaluated, and the difference between wellness devices and regulated medi
This Implantable Artificial Pancreas Could Change Diabetes Care
I speak with Portal Diabetes about how its next-generation implantable pump could bring this technology back—smaller, smarter, and potentially fully closed loop using CGM data. Because insulin is delivered into the intraperitoneal cavity, it acts far faster and clears the body quicker than subcutaneous insulin, which could mean fewer highs and lows and far more spontaneity. I ask them how the pump
How to Use Your Data for Optimal Diabetes Control - ODT
Gary and I take on one of the most important skills in modern diabetes management: understanding and using your data. We break down how to analyze CGM and pump data to identify patterns, trends, and problem areas without getting overwhelmed by numbers. The conversation covers basal insulin, bolus timing, insulin to carb ratios, correction factors, and what metrics like time in range and glucose va
This New AID Uses Biometrics to Automate Insulin - Inside Rheos
Using biometrics like heart rate, stress, and activity to automate insulin delivery in real time, Rheos is a next-generation AID system designed to learn and adapt directly from the body. I sit down with Jonathan Fitch, Founder of GlucoSense, to explore how this settings-free, AI-powered AID system uses wearable data to continuously adapt insulin needs throughout the day. We get into features like
The Risks Behind Easier Insulin Pump Switching
Insulin pump access in the U.S. is changing fast, with more companies moving to pharmacy benefits and making it easier than ever for people with diabetes to start—or switch—systems. While this shift brings more choice and flexibility, it’s also exposing serious challenges around safety, training, and continuity of care. As AID systems become more complex and less interchangeable, switching pumps i
How to Optimize Basal Insulin for Better Glucose Stability - ODT
Co-host Gary Scheiner, CDCES, and I break down basal insulin and why it is the foundation of insulin therapy. We explain what basal insulin does, how it controls liver glucose between meals and overnight, and why incorrect settings can cause constant highs and lows even with advanced diabetes tech. We also cover common basal insulin mistakes, how pumps and automated insulin delivery systems handle
Biggest Diabetes Tech Stories of 2025
2025 delivered major innovations in diabetes tech as well as surprising twists and today we explore the wins, the fails, and what these trends mean for people living with diabetes. I sit down with Kamil Armacky of Nerdabetic to unpack everything from Libre 3 Plus expanding pump integrations, updates and sensor recall, to Dexcom’s new 15-day sensor and how the community feels about it. We also dive
He Built the App Diabetes Tech Was Missing
What happens when diabetes tech doesn’t do what you need—and you decide to build the solution yourself? I sit down with Pablo Medina, who was recently diagnosed with type 1.5 diabetes and built his own iPhone app to fix gaps in insulin patch tracking. We get into his misdiagnosis journey, his experience with devices like InPen, Cequr Simplicity, and why he’s now trialing the Omnipod 5 AID system.
Inside Medtronic‘s New Instinct CGM & What's Next
Medtronic, soon-to-be MiniMed, officially launched its brand-new Instinct CGM in the U.S., a 15-day, no-calibration sensor that pairs seamlessly with the 780G insulin pump. I sit down with Medtronic’s Laura Endres to break down everything. Laura gives us a live demo of the Instinct applicator, explains how it integrates with both the 780G and the upcoming MiniMed Go smart pen platform, and shares
How to Optimize Your CGM Alerts and Settings - ODT
On our new show Optimizing Diabetes Tech (ODT) my co-host Gary Scheiner CDCES and I discuss how people with diabetes can take full advantage of their continuous glucose monitors to make managing Diabetes easier and safer. We get into how to react to alarms, adjust settings, and the features you need to know about. We also answer your questions about CGMs.
Learn about Omnipod 5 (today's sponsor)*
Is Your Pump Secure? A Cybersecurity Expert Breaks It Down
I sit down with Josiah Dykstra—a cybersecurity expert who spent nearly two decades at the NSA and has lived with type 1 diabetes for over 30 years—to explore what diabetes management looks like inside some of the most locked-down buildings in the world. We talk about what happens when your phone, smartwatch, and even certain medical devices are banned; why a standalone Dexcom receiver became essen
The Future of Insulin Pumps: Inside the Next-Gen Pump Wars
I sit down with endocrinologist and diabetes tech expert Dr. David Ahn to unpack the future of tubeless insulin pumps and automated insulin delivery for people with type 1 diabetes. We break down how companies like Omnipod, Tandem (with its tubeless Mobi and 7-day infusion set), Beta Bionics with its reusable mint patch pump, and Medtronic’s upcoming MiniMed Fit are racing to own the next generati
Inside Breakthrough T1D’s Mission to Cure Type 1 Diabetes
I sit down with Breakthrough T1D CEO Dr. Aaron Kowalski to trace his journey—from open-source roots and the early CGM days to leading one of the most influential organizations in diabetes. We dig into how the Artificial Pancreas Project helped make CGMs and AID systems mainstream, and why Aaron believes he’ll one day take off his insulin pump. He breaks down today’s cure pathways—cell replacement
How RenewRx Aims to Transform Diabetes Care During Pregnancy
Pregnancy with diabetes can feel overwhelming—and our healthcare system doesn’t always provide the support people need. In this episode, I talk with Kari Cao and Kelly Carter from RenewRx, a platform transforming prenatal care with behavior-based coaching, CGM insights, and real-time support for both patients and providers. It’s a heartwarming conversation about how they’re filling the gaps in our
The Future of Glucose Monitoring Might Be in Your Brain
Researchers are pushing the boundaries of noninvasive glucose monitoring—by looking to the brain. In this episode, I speak with Dr. Casey Halpern, founder and CEO of SynchNeuro, a startup developing a small wearable that sits behind the ear and reads brainwave activity (EEG) to track glucose levels. The device interprets electrical signals from the hypothalamus and other brain regions to detect sh
How "Helicopter Parents" Pioneered CGM on Smartwatches Before Pharma
Before CGM data hit Apple Watches or official apps, Kate Farnsworth and a community of determined parents made it happen themselves. Labeled “helicopter parents” by companies Dexcom, they soldered devices, coded software, and launched Nightscout—the first way to view glucose data remotely. Kate went on to found the Looped Facebook group helping over 30,000 families build their own open-source insu
Inside the Twiist Pump: What Users Think After One Month
The twiist insulin pump from Sequel Med Tech is finally in users’ hands—and people have thoughts! I sas down with two early adopters, Sean Wilkinson and nurse practitioner Jori Matushek, to discuss their first month using twiist. They dive into everything from the algorithm’s unique features—like emoji-based bolusing and retroactive carb adjustments—to infusion set design, occlusion detection, and
Inside the Medtrum Tubeless AID System – A User’s Experience
This episode explores the Medtrum automated insulin system, a tubeless patch pump available across Europe, Argentina, New Zealand and more. Mariska Francke shares her experience after two years on the pump and four months using the Medtrum Nano CGM—covering setup, app use, alerts, and what it’s like day-to-day. She opens up about improved sleep, accuracy challenges, and what’s ahead with Medtrum’s
From Control Loops to Simulations: How We Get Faster Diabetes Tech Approvals
I sit down with engineer and diabetes innovator Lane Desborough to explore how control loops shape our everyday lives—and why they’re the foundation of diabetes technology. Lane shares his journey from building Nightscout to pioneering new ways to speed up diabetes device innovation. We dive into his latest work using simulations to help regulators clear devices faster, without sacrificing safety.
The Future of Insulin: Where We Are Now & What's Next
From inhaled insulin to an oral smart insulin pill the future of insulin innovation is bright! David Ahn and I discuss the history of insulin, why it is slower than insulin produced from the pancreas and the standings of insulin research in the works, such as once-a-week long-acting insulin injections.
Join the Diabetech Newsletter
Learn about Omnipod 5 (today's sponsor)*
T1D Exchange Regist
What is Type 3C Diabetes? A Diagnosis Story & Explainer
We dive into type 3C diabetes, a lesser-known form that develops after pancreatic damage from pancreatitis, surgery, or trauma. Ivan Werning breaks down how it differs from type 1 and type 2, the challenges of delayed diagnosis, and the realities of managing both blood sugar and digestion. We also explore how he uses the CeQur Simplicity insulin patch why awareness of this rare condition is so imp
Tandem’s New Tech: Tubeless Mobi Preview & 7-Day Infusion Set Demo
I sit down with Tandem Diabetes' Senior Director of Product Marketing, Ben Mar, to unpack all the big tech coming from the company and recent safety warnings users should be aware of. We get the first public video demo of the 7-day SteadiSet infusion set, unpack the upcoming tubeless Mobi option, and Ben shares updates on Libre 3 Plus integration and an Android app coming soon. I also asked Ben a
Why Diabetes Tech Innovation Is So Slow & The Work To Speed It Up
Diabetes tech often advances slowly because of hard constraints: safety, liability, FDA clearance, and reimbursement—so apps take years, pump designs stagnate, and algorithms lag behind what’s possible. In this episode, we unpack how those forces shape timelines and what’s being done to move faster without sacrificing safety. Joining me is Shannon Lantzy, a regulatory innovation expert who started
Inside Loop’s Experimental AI-Powered Food Search
DIY Loop user Taylor Patterson built an AI-powered food analysis tool right into the AID app—helping users take pictures, scan barcodes, or enter text and voice prompts to get carb estimates, nutrition breakdowns, and diabetes-oriented notes. In this episode, Taylor explains how he created the feature in just 30 minutes, how it’s already helping him improve his time in range, and why AI could chan
ADCES 2025: The Future of Diabetes Care, New Tech & Cure Progress
We cover ADCES 2025 updates on how diabetes educators are adapting to AI, new insights on mental health and eating disorders in type 1, and eye-opening stats about access to care. We also dive into the latest diabetes tech, including the Pivot pump, DIY systems, and carb awareness research. And lastly, we discuss major progress toward a cure for type 1 diabetes, with companies like Vertex and Sana
T1Ds are Using GLP-1s: The Latest Research & The Road to Coverage
We dive into the growing off-label use of GLP-1 medications like Ozempic, Wegovy, and Mounjaro among people with type 1 diabetes. I'm joined by longtime diabetes advocate and healthcare executive Marie Schiller to explore the benefits, risks, and evolving research around these drugs. We discuss new studies, including the ADJUST-T1D trial, showing improved A1C, increased time in range, reduced insu
How AI-Powered Food Logging Could Transform Diabetes Management
AI-powered food tracking is changing how people with diabetes count carbs and manage their glucose. In this episode, I speak with Aurelian Briner, CEO and co-founder of the SNAQ app—an AI-driven diabetes app that uses photos, voice notes, and machine learning to estimate carbs, log meals, and predict glucose spikes. We dive into how AI is transforming diabetes management, the importance of persona
How DIYers Beat Pharma to the First Automated Insulin Delivery System
This episode explores the early days of diabetes data integration and the rise of open-source AID systems with Brandon Arbiter, Co-Founder and Acting CEO of Tidepool. Brandon shares how his passion for location data led to the creation of Tidepool, now a key platform in diabetes tech. We discuss the pivotal people who shaped the open source space, big moments in the development of AID systems, Tid
Speaking with Dexcom: Sensor Failures, Recalls & The Future of CGM
Dexcom addresses growing concerns over G7 sensor failures, the recall of receivers with faulty alerts, and an FDA warning letter. We also discuss the upcoming 15-day Dexcom G7, AI food tracking and a new integration between Stelo and Oura Ring. Drop your questions and comments on YouTube.
Join our Newsletter
Learn about Omnipod 5 (today's sponsor)*
T1D Exchange Registry Sign up (US resident
How One Advocate Advanced Diabetes Tech Accessibility
In this episode, Justin speaks with Melissa Holloway, the founder of SmartStart and a type 1 for over 30 years, opens up about her personal fight to access an insulin pump after moving to the UK—and how that journey led her to become a force for change in the diabetes community. Together, they explore how one voice can make a difference and why community-driven events like Friends for Life are so
Biggest Diabetes Tech & Research Reveals from ADA 2025
We break down the biggest diabetes tech and research highlights from the 2025 ADA Scientific Sessions. Justin is joined by CDCES Gary Scheiner to discuss new tubeless insulin pumps, an implantable continuous glucose monitor, and updates on a dual glucose-ketone sensor. We also explore cutting-edge research on islet cell therapies, ultra-concentrated insulins, and the potential of amylin as a compl
World Traveling As A T1D - Everything We've Learned
In this live episode of Diabetech, I'm joined by Jen Greaves in Valencia, Spain! Jen is a fellow T1D, world traveler, and content creator who spent four months exploring Latin America—all while managing life with type 1. We talk about what it takes to travel long-term with T1D, from navigating insulin supply challenges to staying on top of tech and routines while constantly on the move. Now that I
Traveling With Diabetes - Expert Tips From My Diabetes Educator
Over the last 8 months, I’ve been traveling the world as a digital nomad, and I want everyone with diabetes to know—it is possible to travel safely and confidently. Today I'm joined by my diabetes educator, Mary Rose, who helped guide me through my very first trip with type 1 diabetes! Mary Rose and I cover everything from what to pack and how to prep with your care team, to airport security tips,
Dexcom G7 Failures & Fixes - What You Need To Know
We dive into growing concerns around reliability issues with the Dexcom G7. After posting a video online that sparked nearly 1,000 comments from users reporting sensor failures, it became clear that this wasn’t an isolated problem. To explore what’s going on, I’m joined by two experts in the diabetes space: Kamil of the Nerdabetic YouTube channel, and Dr. David Ahn, a practicing endocrinologist. W
She Believed CGM Would Change Patient Lives—And She Was Right
Today we explore the evolution of continuous glucose monitors (CGMs) — from the first professional CGM in 1999 to the advanced tech driving today’s AID systems, and how these devices changed patient lives along the way. Dr. Grazia Aleppo, a leading endocrinologist and early CGM believer, joins to discuss early CGM innovations, the challenges of adoption, and pivotal research that expanded global a
Using The First Insulin Pump: A Journey Through Diabetes History
I sit down with someone who wore the first consumer insulin pump—the AutoSyringe We dive into what diabetes treatment was like at the time, how the early pump worked, and how decades of evolving tech have shaped her journey and inspired her to educate others. It’s a powerful look at how far we’ve come in diabetes innovation.
Learn about Omnipod 5 (today's sponsor)*
T1D Exchange Registry Sign
This Video Game Helps People Learn Type 1 Diabetes
I sit down with veteran game developer and T1D dad Sam Glassenberg, creator of Level One—a new smartphone game designed to teach newly diagnosed patients and their families the fundamentals of T1D management. From insulin-to-carb ratios to the impact of exercise and fat on blood sugar, Level One turns complex concepts into fun, interactive levels. With early praise from endocrinologists and patien
A CGM That Measures Blood Is Coming - What You Should Know
Today’s CGMs measure glucose through fluid under the skin—but what if we could measure it directly from the blood? Today we explore Glucotrack, an implantable device that could become the world’s first continuous blood glucose monitor (CBGM). I’m joined by Glucotrack's CEO and Chief Scientific Officer to discuss the major advantages this device could offer over today’s CGMs. We cover how the senso
Tandem Mobi Deep Dive - 3 Months Using the Pump
I share my experience after nearly three months using the Tandem Mobi, the smallest tubed hybrid closed-loop pump currently available in the U.S. I’m joined by diabetes educator and fellow Mobi user David Mina to dive deep into how Tandem’s Control-IQ algorithm works — including updates with Control-IQ+ — and what to consider before switching from other pumps like the Omnipod. We also discuss Davi
How T1D Hackers Beat Pharma to Remote CGM Monitoring
We take a journey back to the roots of the #WeAreNotWaiting movement—before CGM follower apps—when a group of determined parents and developers built their own tools to monitor glucose remotely. I sit down with James Wedding, founder of the Nightscout Foundation, to talk about the early days of Nightscout, how it transformed life for families managing diabetes, and the powerful role the open-sourc
Insulin Pumps Are Moving to Pharmacies — Here’s Why It Matters
In this episode, we dive into the major shift happening in the U.S. diabetes tech industry: insulin pumps are moving from Durable Medical Equipment (DME) to pharmacy benefits, offering easier access, lower costs, and more flexibility for users. I’m joined by Jeff DelVerne, author of The Healthcare Economy Substack and Director of Payer Relations at Beta Bionics, to break down what this transition
How A Diabetes Blogger Changed The Game
In this episode, I sit down with Amy Tenderich, one of the first diabetes bloggers, whose open letter to Steve Jobs called for better, more user-friendly diabetes technology. That bold move launched her deeper into the world of diabetes advocacy and innovation, eventually leading her to create D-Data Exchange—a powerful forum where industry leaders, regulators, and patient voices come together to
This Could Prevent Type 1 Diabetes - SAB-142 Explained
Can we stop type 1 diabetes before it starts? I’m joined by Sam Reich, CEO of SAB Bio, and Dr. Mike Haller, a leading T1D researcher, to explore an innovative new therapy called SAB-142. Unlike traditional thymoglobulin, which is derived from rabbits, SAB’s therapy uses a fully human version produced by genetically engineered cows—potentially eliminating harmful side effects like serum sickness. W
Getting Started on AAPS - The Open Source AID for Android
We explore Android APS (AAPS)—a powerful open-source automated insulin delivery system that runs on Android phones and uses the advanced o-ref algorithm. AAPS offers features like Dynamic ISF (Insulin Sensitivity Factor), Dynamic CR (Carb Ratio), Unannounced Meal detection (UAM), and Super Micro Boluses (SMBs), making it one of the most customizable diabetes tech options out there. Our guest, Aust
The Twiist Pump is Coming - What You Need to Know
The twiist insulin pump from Sequel Med Tech is releasing in Q2 of 2025. is bringing a new spin to tubed pump therapy. I met with Sequel's CEO to dive into twiist's launch CGM integration with Libre 3 Plus to its advanced occlusion technology designed for more reliable insulin delivery. We also break down how patients will access twiist through pharmacy benefit managers, a shift that could make th
ATTD 2025: The Biggest Diabetes Tech Announcements
Endocrinologist David Ahn and I break down the biggest diabetes tech announcements from the ATTD conference in Amsterdam! We dive into the highly anticipated Twiist pump, the newly unveiled and more powerful Kaleido 2, Tandem’s game-changing Control IQ+ algorithm update, Dexcom’s 15-day sensor, and more. This was a HUGE week for diabetes innovation—What are you most excited for? Let us know on You
Recommended
Yours Truly Johnny Dollar Collection
Take Back Your Health®
CBS Radio Mystery Theater | Old Time Radio
Solved Murders - True Crime Stories
紐約鳥｜New York Aperture
The Swerve Podcast: Obscure Topics | Conspiracy Theories
The Bread and Banter Podcast
The Church of What's Happening Now: The New Testament
Busted Open
Deadline: White House
Crickets Corner
History of the Earthquake and Fire in San Francisco
